# Teniposide Incorporating Bu/Cy Conditioning Regimen for HLH With Central Nervous System Involvemen

> **NCT06048107** · NA · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 20 (estimated)

## Conditions studied

- HLH

## Interventions

- **DRUG:** Teniposide

## Key facts

- **NCT ID:** NCT06048107
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-22
- **Primary completion:** 2024-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06048107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06048107, "Teniposide Incorporating Bu/Cy Conditioning Regimen for HLH With Central Nervous System Involvemen". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06048107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*